PORxin: Completed Phase IIb enrollment

Protox completed enrollment of 92 patients with moderate to severe BPH in the double-blind, placebo-controlled, Canadian Phase IIb TRIUMPH trial evaluating 3 µg/mL of PRX302 injected into the prostate...